Key Dates

Related Announcements

PAR-20-108 - International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

This Notice informs potential applicants of modifications to the description of Funds Available and Anticipated Number of Awards for Funding Opportunity Announcement (FOA) PAR-20-108, “International Research in Infectious Diseases (R01 Clinical Trial Not Allowed).”

Effective immediately, the following section of of PAR-20-108 has been modified as indicated below:

Part 2. Section II. Award Information

Funds Available and Anticipated Number of Awards

Currently Reads:

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications

Modified to Read (changes shown in bold italics):

NIAID intends to commit an estimated total of $1.4 million to fund 6-10 awards in FY2022, depending on the number of meritorious applications.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Glen C. McGugan, Jr., Ph.D.
Division of Microbiology and Infectious Diseases (DMID)
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3314
Email: [email protected]

HIV/AIDS:

Melanie C. Bacon, R.N., M.P.H.
Division of AIDS (DAIDS)
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3215
Email: [email protected]

David McDonald, Ph.D.
Division of AIDS (DAIDS)
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-761-7815
Email: [email protected]